These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16080017)

  • 1. High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma.
    Kamata Y; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Hattori M; Obokata A; Kuramoto H
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):591-6. PubMed ID: 16080017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
    Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
    Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
    Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance.
    Kato N; Watanabe J; Jobo T; Nishimura Y; Fujisawa T; Kamata Y; Kuramoto H
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):222-6. PubMed ID: 12684894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
    Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
    Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters.
    Watanabe J; Sato H; Kanai T; Kamata Y; Jobo T; Hata H; Fujisawa T; Ohno E; Kameya T; Kuramoto H
    Br J Cancer; 2002 Jul; 87(1):81-5. PubMed ID: 12085261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.
    An HJ; Lee YH; Cho NH; Shim JY; Kim JY; Lee C; Kim SJ
    Histopathology; 2002 Nov; 41(5):437-45. PubMed ID: 12405911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
    Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse correlation between Skp2 and p27(Kip1) in normal endometrium and endometrial carcinoma.
    Miyamoto T; Horiuchi A; Kashima H; Suzuki A; Yamada T; Kurai M; Konishi I; Shiozawa T
    Gynecol Endocrinol; 2010 Mar; 26(3):220-9. PubMed ID: 19724954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas.
    Cao QJ; Einstein MH; Anderson PS; Runowicz CD; Balan R; Jones JG
    Int J Gynecol Pathol; 2002 Apr; 21(2):147-54. PubMed ID: 11917224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclins A, B, E and p27 in Endometrial Endometrioid Adenocarcinoma.
    Santala S; Talvensaari-Mattila A; Soini Y; Kuvaja P; Santala M
    Anticancer Res; 2016 Dec; 36(12):6467-6473. PubMed ID: 27919969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.
    Hotton J; Agopiantz M; Leroux A; Charra-Brunaud C; Marie B; Busby-Venner H; Morel O; Guéant JL; Vignaud JM; Battaglia-Hsu SF; Gauchotte G
    Virchows Arch; 2018 Apr; 472(4):623-633. PubMed ID: 29243125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase Skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium.
    Lahav-Baratz S; Ben-Izhak O; Sabo E; Ben-Eliezer S; Lavie O; Ishai D; Ciechanover A; Dirnfeld M
    Mol Hum Reprod; 2004 Aug; 10(8):567-72. PubMed ID: 15220466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
    Ozuysal S; Oztürk H; Bilgin T; Filiz G
    Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator.
    Shih HC; Shiozawa T; Kato K; Imai T; Miyamoto T; Uchikawa J; Nikaido T; Konishi I
    Hum Pathol; 2003 May; 34(5):471-8. PubMed ID: 12792921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas.
    Brüning A; Jückstock J; Blankenstein T; Makovitzky J; Kunze S; Mylonas I
    Histol Histopathol; 2010 Nov; 25(11):1447-56. PubMed ID: 20865667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.
    Alkushi A; Lim P; Coldman A; Huntsman D; Miller D; Gilks CB
    Int J Gynecol Pathol; 2004 Apr; 23(2):129-37. PubMed ID: 15084841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.